Swiss pharmaceutical company Novartis reported better-than-expected sales in Q4, with net sales rising 16% to $13.2 billion, exceeding analyst estimates. However, full-year sales fell short of guidance at $50.32 billion, while core operating income for 2024 increased to $19.5 billion. CEO Vas Narasimhan highlighted the company’s strong financial performance and growth outlook for 2025, focusing on advancing their development pipeline with over 30 assets for long-term growth.
Full Article
Tim Dolighan cartoon, March 10, 2025
Tim Dolighan's cartoon from March 10, 2025, is featured in the article. The video failed to load, but readers can access other videos from the team by refreshing their browser. The cartoon likely includes humorous or satirical content related to current events or popular culture. Full Article
Read more